newsfilter
← Latest News
GlobeNewswire·

BioXcel Therapeutics Announces $14 Million Registered Direct Offering

NEW HAVEN, Conn., March 03, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the "Company") (NASDAQ:BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in